2022 ASGCT poster presentation: Overcoming Therapeutic Deficiencies in Lysosomal Storage Disease Treatments Using Directed Evolution
Poster abstract:
Using our proprietary CodeEvolver® protein engineering platform, which entails high-throughput protein expression, high-throughput activity and cell-based assays, next-generation sequencing, and bioinformatics, we have identified α-galactosidase A (GLA) and α-glucosidase (GAA) variants with superior properties for addressing Fabry and Pompe diseases, respectively.
Download